Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel T Rein

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Anti-Cancer Drugs|March 12, 2004
Dysregulation of protein kinase C activity in chemoresistant metastatic breast cancer cellsThomas Schöndorf, Markus Hoopmann, Martina Breidenbach, et al.
Anti-Cancer Drugs|September 27, 2006
Anticancer drugs induce mdr1 gene expression in recurrent ovarian cancerStephanie Hille, Daniel T Rein, Marion Riffelmann, et al.
Journal of Reproductive Immunology|February 13, 2002
Cytokine expression in peripheral blood lymphocytes indicates a switch to T(HELPER) cells in patients with preeclampsiaDaniel T Rein, Thomas Schondorf, Uwe Jochen Gohring, et al.
Fertility and Sterility|June 16, 2009
Treatment of endometriosis with a VEGF-targeted conditionally replicative adenovirusDaniel T Rein, Torsten Schmidt, Gerd Bauerschmitz, et al.
Journal of Cancer Research and Clinical Oncology|January 3, 2012
Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancerDaniel T Rein, Anne Volkmer, Gerd Bauerschmitz, et al.
Cancer Letters|November 8, 2005
A new targeting approach for breast cancer gene therapy using the heparanase promoterMartina Breidenbach, Daniel T Rein, Thomas Schöndorf, et al.
Oncology Letters|June 29, 2012
Systemic administration of bevacizumab prolongs survival in an in vivo model of platinum pre-treated ovarian cancerDaniel T Rein, Anne Kathrin Volkmer, Jens Volkmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
A fiber-modified mesothelin promoter-based conditionally replicating adenovirus for treatment of ovarian cancerYuko Tsuruta, Larisa Pereboeva, Martina Breidenbach, et al.
Gynecologic Oncology|July 12, 2011
Treatment of chemotherapy resistant ovarian cancer with a MDR1 targeted oncolytic adenovirusDaniel T Rein, Anne Volkmer, Ines M Beyer, et al.
International Journal of Cancer|July 15, 2004
Gene transfer to cervical cancer with fiber-modified adenovirusesDaniel T Rein, Martina Breidenbach, Hongju Wu, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Anti-Cancer Drugs|March 12, 2004
Dysregulation of protein kinase C activity in chemoresistant metastatic breast cancer cellsThomas Schöndorf, Markus Hoopmann, Martina Breidenbach, et al.
Anti-Cancer Drugs|September 27, 2006
Anticancer drugs induce mdr1 gene expression in recurrent ovarian cancerStephanie Hille, Daniel T Rein, Marion Riffelmann, et al.
Journal of Reproductive Immunology|February 13, 2002
Cytokine expression in peripheral blood lymphocytes indicates a switch to T(HELPER) cells in patients with preeclampsiaDaniel T Rein, Thomas Schondorf, Uwe Jochen Gohring, et al.
Fertility and Sterility|June 16, 2009
Treatment of endometriosis with a VEGF-targeted conditionally replicative adenovirusDaniel T Rein, Torsten Schmidt, Gerd Bauerschmitz, et al.
Journal of Cancer Research and Clinical Oncology|January 3, 2012
Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancerDaniel T Rein, Anne Volkmer, Gerd Bauerschmitz, et al.
Cancer Letters|November 8, 2005
A new targeting approach for breast cancer gene therapy using the heparanase promoterMartina Breidenbach, Daniel T Rein, Thomas Schöndorf, et al.
Oncology Letters|June 29, 2012
Systemic administration of bevacizumab prolongs survival in an in vivo model of platinum pre-treated ovarian cancerDaniel T Rein, Anne Kathrin Volkmer, Jens Volkmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
A fiber-modified mesothelin promoter-based conditionally replicating adenovirus for treatment of ovarian cancerYuko Tsuruta, Larisa Pereboeva, Martina Breidenbach, et al.
Gynecologic Oncology|July 12, 2011
Treatment of chemotherapy resistant ovarian cancer with a MDR1 targeted oncolytic adenovirusDaniel T Rein, Anne Volkmer, Ines M Beyer, et al.
International Journal of Cancer|July 15, 2004
Gene transfer to cervical cancer with fiber-modified adenovirusesDaniel T Rein, Martina Breidenbach, Hongju Wu, et al.
Pageof 3